Clinical Trial Update: Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical pharmacology study evaluating oral edaravone in Japanese patients with amyotrophic lateral sclerosis has completed, with results posted on 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Edaravone (Edaravone)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Japanese Patients With ALS | Phase 1 | Status: COMPLETED | Results posted: 2024-01-24